The following bids, mergers, acquisitions and disposals were reported by 1600 GMT on Tuesday:** Eli Lilly and Co said it would purchase Swiss drugmaker Novartis AG's animal health business for $5.4 billion in cash to strengthen and diversify its Elanco unit.** Canada's Valeant Pharmaceuticals International Inc said it has partnered with activist investor Bill Ackman in an unsolicited $47 billion bid to buy Botox maker Allergan Inc in a move to eventually become one of the world's five biggest drug companies.
Allergan, Inc. is a multi-specialty health care Company focused on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products. Shares of AGN traded higher by 15.61% or $22.17/share to $164.17. In the past year, the shares have traded as low as $81.33 and as high as $142.00. On average, 3082310 shares of AGN exchange hands on a given day and today's volume is recorded at 20755352.
Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX traded higher by 5.79% or $7.2899/share to $133.30. In the past year, the shares have traded as low as $71.99 and as high as $153.10. On average, 1992590 shares of VRX exchange hands on a given day and today's volume is recorded at 10438409.
Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX traded higher by 5.84% or $8.1/share to $146.86. In the past year, the shares have traded as low as $72.59 and as high as $170.45. On average, 372348 shares of VRX.TO exchange hands on a given day and today's volume is recorded at 632085.
Source
